The Northeast Regional Center for Excellence in Vector-Borne Diseases, led by Cornell, has received a five-year, $8.7 million award from the Centers for Disease Control and Prevention to train and educate vector-borne disease professionals.
Cornell University’s Life Sciences Technology Innovation Fellowship, formerly known as the BioEntrepreneurship Initiative, enters its second year in 2023-24 with a new cohort of 15 business students and 12 researchers.
The $1.7 million grant will help scientists with expertise in artificial intelligence and machine learning to address complex biomedical challenges in nutrition and health.
A member of an important class of ion channel proteins can transiently rearrange itself into a larger structure with dramatically altered properties, according to a study led by researchers at Weill Cornell Medicine.
A new study testing the accuracy of existing methods used to predict the genetic variation that cause infertility found that relying on computational or in vitro experiments alone is insufficient.
An international phase 3 clinical trial found that a new targeted treatment, given in combination with a standard chemotherapy, extended survival for select patients with advanced gastric or gastroesophageal junction cancer.
Severe COVID-19 infection triggers changes that affect gene expression in immune system stem cells, causing alterations in the body’s immune response, according to a new study by Weill Cornell Medicine and Jackson Laboratory investigators.
